Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19

Objective: Although type 2 diabetes mellitus (T2DM) has been reported as a risk factor for coronavirus disease 2019 (COVID-19), the effect of pharmacologic agents used to treat T2DM, such as metformin, on COVID-19 outcomes remains unclear. Metformin increases the expression of angiotensin converting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Endocr Pract
Autores principales: Li, Jinghong, Wei, Qi, Li, Willis X, McCowen, Karen C, Xiong, Wei, Liu, Jiao, Jiang, Wenlijun, Marin, Traci, Thomas, Robert L, He, Ming, Gongol, Brendan, Hepokoski, Mark, Yuan, Jason X-J, Shyy, John Y-J, Xiong, Nian, Malhotra, Atul
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Inc. 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834011/
https://ncbi.nlm.nih.gov/pubmed/33471718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/EP-2020-0466
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares